The disease symptoms and treatments

Multiple sclerosis (MS) is the most common neurological disorder among young adults and often results in a handicap. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.

News

14.06.19

155 days of research

There are many ways to support research: on the occasion of a wedding, a birthday, a neighbors' party, a BBQ, being sponsored during a race or a walk. It's all up to you: our "Action" platform is waiting for you here.

The 104 runners of the Charcot team of the 20 k - Brussels 2019, set an example: together they raised enough money to fund 155 days of research in multiple sclerosis! The next edition of the 20 km will take place on May 31, 2020 and registration will begin on December 15, 2019.

 

 

Make a gift

20 km of Brussels run or support

Support an action

Start your action

Leave a legacy

Laureates of Charcot Fund 2019

All laureates

Grant

€ 45,530

Prof. Dr. Muriel Moser and Dr. Isabel Vogel

The project

Exploring the effect of CD27/CD70 costimulation on Th17 vs. Treg cells during autoimmunity
ULB
Detail of the grant

Grant

€ 40,000 € / 2 years

Dr. Tim Vanmierlo, Prof. Daniel van den Hove and Mrs Assia Tiane

The project

The epigenetic signature of myelin genes as an innovative biomarker for progressive multiple sclerosis
UHasselt
Detail of the grant

Grant

€ 54,550 / 2 years

Prof. Tom Vanden Berghe and Prof. Peter Vandenabeele

The project

Therapeutic exploration of novel inhibitors of biological rust in multiple sclerosis
UGent
Detail of the grant

Grant

€ 45.000 / 2 years

Dr. Judith Fraussen and Prof. Veerle Somers

The project

Age-associated B cells as therapeutic targets in MS
BIOMED- UHasselt
Detail of the grant

Grant

€ 42,000 / 2 years

Dr. Guy Laureys, Prof. Veerle Somers and Dr. Judith Fraussen

The project

Autologous hematopoietic stem cell transplantation (AHSCT) in MS: a role for B cells?
UZ Gent and UHasselt-BIOMED
Detail of the grant

Grant

€ 53,000 / 2 years

Prof. Jerome Hendriks, Prof. Johan Swinnen and Dr. Jeroen Bogie

The project

Boosting lesion repair in multiple sclerosis by preventing lipid overload in phagocytes
BIOMED- UHasselt
Detail of the grant

Grant

€ 40,000 € / 2 years

Prof. Anne des Rieux

The project

Remyelination stimulation by activin A delivery via MSC-derived extracellular vesicles.
UCLouvain
Detail of the grant

Grant

€ 47,424 / 2 years

Dr. Inna Afonina and Prof. Rudi Beyaert

The project

Characterization of interleukin-33 (IL-33) as a potential therapeutic target in multiple sclerosis
VIB-UGent Center for Inflammation Research
Detail of the grant

Grant

€ 40,000 / 2 years

Prof. An Goris and Prof. Patrick Matthys

The project

Characterization of regulatory B-cell subsets emerging in multiple sclerosis treatment
KU Leuven
Detail of the grant

Grant

€ 43,000 / 2 years

Dr. Debbie Leblon and Prof. Peter Ponsaerts

The project

The development of a human iPSC-derived in vitro demyelination model for studying the effect of IL13-induced M2-activated macrophages and microglia
U Antwerpen
Detail of the grant

Grant

€ 50,000 / 2 years

Prof. Anje Cauwels

The project

In vivo induction of tolerogenic Dendritic Cells via AcTaferon targeting
UGent / VIB
Detail of the grant

Last newsletter

Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study

MAY 2019